|Bid||0.00 x 1300|
|Ask||341.93 x 1100|
|Day's range||333.24 - 353.60|
|52-week range||54.10 - 353.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||195.09|
Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
University of Alabama at Birmingham Associate Dean for Global Health Dr. Michael Saag joins Yahoo Finance Live to discuss the latest COVID-19 updates as the delta variant raises concerns.
(Bloomberg) -- Sanofi will buy its messenger-RNA development partner Translate Bio Inc. for $3.2 billion as the French drugmaker plays catch-up in deploying the technology behind some of the world’s top-selling Covid-19 vaccines.Sanofi agreed to pay $38 in cash for each of Translate Bio’s shares. While the price is 30% above Monday’s closing price, the company is getting a potential bargain “in a very hot therapeutic area,” said Wimal Kapadia, an analyst at Bernstein.Ordinarily a giant in the va